Taiwan · Delayed Price · Currency is TWD HeXun Biosciences Statistics
Total Valuation
TPEX:6986 has a market cap or net worth of TWD 2.24 billion. The enterprise value is 1.44 billion.
| Market Cap | 2.24B |
| Enterprise Value | 1.44B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Aug 18, 2026 |
Share Statistics
TPEX:6986 has 52.13 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 52.13M |
| Shares Outstanding | 52.13M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +1.00% |
| Owned by Insiders (%) | 28.69% |
| Owned by Institutions (%) | n/a |
| Float | 31.43M |
Valuation Ratios
The trailing PE ratio is 17.04.
| PE Ratio | 17.04 |
| Forward PE | n/a |
| PS Ratio | 7.26 |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | 16.64 |
| P/OCF Ratio | 13.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.27, with an EV/FCF ratio of 10.74.
| EV / Earnings | 12.42 |
| EV / Sales | 4.69 |
| EV / EBITDA | 9.27 |
| EV / EBIT | 11.07 |
| EV / FCF | 10.74 |
Financial Position
The company has a current ratio of 12.14, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.14 |
| Quick Ratio | 11.69 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.26 |
| Interest Coverage | 122.82 |
Financial Efficiency
Return on equity (ROE) is 13.26% and return on invested capital (ROIC) is 39.60%.
| Return on Equity (ROE) | 13.26% |
| Return on Assets (ROA) | 8.31% |
| Return on Invested Capital (ROIC) | 39.60% |
| Return on Capital Employed (ROCE) | 11.87% |
| Weighted Average Cost of Capital (WACC) | 4.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 53 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.38 |
Taxes
In the past 12 months, TPEX:6986 has paid 24.89 million in taxes.
| Income Tax | 24.89M |
| Effective Tax Rate | 17.62% |
Stock Price Statistics
The stock price has decreased by -32.57% in the last 52 weeks. The beta is 0.09, so TPEX:6986's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -32.57% |
| 50-Day Moving Average | 48.94 |
| 200-Day Moving Average | 56.71 |
| Relative Strength Index (RSI) | 31.65 |
| Average Volume (20 Days) | 65,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6986 had revenue of TWD 308.21 million and earned 116.33 million in profits. Earnings per share was 2.52.
| Revenue | 308.21M |
| Gross Profit | 280.37M |
| Operating Income | 130.56M |
| Pretax Income | 141.21M |
| Net Income | 116.33M |
| EBITDA | 155.92M |
| EBIT | 130.56M |
| Earnings Per Share (EPS) | 2.52 |
Balance Sheet
The company has 828.93 million in cash and 34.61 million in debt, with a net cash position of 794.32 million or 15.24 per share.
| Cash & Cash Equivalents | 828.93M |
| Total Debt | 34.61M |
| Net Cash | 794.32M |
| Net Cash Per Share | 15.24 |
| Equity (Book Value) | 1.07B |
| Book Value Per Share | 23.13 |
| Working Capital | 877.92M |
Cash Flow
In the last 12 months, operating cash flow was 163.80 million and capital expenditures -29.24 million, giving a free cash flow of 134.56 million.
| Operating Cash Flow | 163.80M |
| Capital Expenditures | -29.24M |
| Depreciation & Amortization | 25.36M |
| Net Borrowing | -3.88M |
| Free Cash Flow | 134.56M |
| FCF Per Share | 2.58 |
Margins
Gross margin is 90.97%, with operating and profit margins of 42.36% and 37.74%.
| Gross Margin | 90.97% |
| Operating Margin | 42.36% |
| Pretax Margin | 45.82% |
| Profit Margin | 37.74% |
| EBITDA Margin | 50.59% |
| EBIT Margin | 42.36% |
| FCF Margin | 43.66% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 0.51%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | 0.35% |
| Earnings Yield | 5.20% |
| FCF Yield | 6.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |